AU6025296A - Pharmaceutical compositions containing calcium sulfate - Google Patents

Pharmaceutical compositions containing calcium sulfate

Info

Publication number
AU6025296A
AU6025296A AU60252/96A AU6025296A AU6025296A AU 6025296 A AU6025296 A AU 6025296A AU 60252/96 A AU60252/96 A AU 60252/96A AU 6025296 A AU6025296 A AU 6025296A AU 6025296 A AU6025296 A AU 6025296A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
compositions containing
calcium sulfate
containing calcium
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60252/96A
Other languages
English (en)
Inventor
Rolland F. Hebert
Sohail Malik
Min Yee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofrontiers Inc
Original Assignee
Biofrontiers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/449,949 external-priority patent/US5683725A/en
Application filed by Biofrontiers Inc filed Critical Biofrontiers Inc
Publication of AU6025296A publication Critical patent/AU6025296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU60252/96A 1995-05-25 1996-05-28 Pharmaceutical compositions containing calcium sulfate Abandoned AU6025296A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US45026195A 1995-05-25 1995-05-25
US08/449,949 US5683725A (en) 1995-05-25 1995-05-25 Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
US449949 1995-05-25
US450261 1995-05-25
US52924495A 1995-09-15 1995-09-15
US529244 1995-09-15
PCT/US1996/007874 WO1996037207A2 (fr) 1995-05-25 1996-05-28 Compositions pharmaceutiques contenant du sulfate de calcium

Publications (1)

Publication Number Publication Date
AU6025296A true AU6025296A (en) 1996-12-11

Family

ID=27412423

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60252/96A Abandoned AU6025296A (en) 1995-05-25 1996-05-28 Pharmaceutical compositions containing calcium sulfate

Country Status (3)

Country Link
EP (1) EP0839043A2 (fr)
AU (1) AU6025296A (fr)
WO (1) WO1996037207A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
CA2287397A1 (fr) * 1997-04-24 1998-10-29 Merck Sharp & Dohme Limited Utilisation d'un antagoniste du recepteur nk-1 et d'un inhibiteur selectif de reabsorption de la serotonine (ssri) dans le traitement de l'obesite
EP0977572A1 (fr) * 1997-04-24 2000-02-09 Merck Sharp & Dohme Ltd. Utilisation des antagonistes du recepteur de nk-1 dans le traitement des troubles alimentaires
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689223A (en) * 1986-04-24 1987-08-25 T & R Chemicals, Inc. Method of treating the symptoms of the common cold
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
AU1936788A (en) * 1987-06-01 1989-01-04 Allergan, Inc. Preservative free ophthalmic ointments
US4915936A (en) * 1988-10-31 1990-04-10 United States Gypsum Company Dental hygiene composition for reducing periodontal disease
JPH08502976A (ja) * 1992-10-29 1996-04-02 シー−ピー テクノロジー リミテッド パートナーシップ カルシウムおよび硫酸塩を含有した組成物および複合体、その合成法、これを用いた治療法、これを含んでなる化粧用調製物
DE69413544T2 (de) * 1993-08-24 1999-05-27 Kappa Pharmaceuticals Ltd., Reading Reduzierte absorption von fettsäuren
JPH0899848A (ja) * 1994-10-03 1996-04-16 Yoshinori Akiyama 歯槽膿漏治療剤

Also Published As

Publication number Publication date
WO1996037207A2 (fr) 1996-11-28
WO1996037207A3 (fr) 1997-02-27
EP0839043A2 (fr) 1998-05-06

Similar Documents

Publication Publication Date Title
AU6216296A (en) Pharmaceutical compositions
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
HU9601698D0 (en) Pharmaceutical composition
AUPN411195A0 (en) Medicinal composition
AU6418596A (en) Compounds and pharmaceutical compositions containing them
ZA967827B (en) Pharmaceutical compositions
GB9519667D0 (en) Pharmaceutical composition
AU5155096A (en) Pharmaceutical composition
EG24294A (en) Pharmaceutical compositions
AU5274096A (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
GB9525194D0 (en) Pharmaceutical composition
GB9502695D0 (en) Pharmaceutical composition
AU6025296A (en) Pharmaceutical compositions containing calcium sulfate
AU6814496A (en) Pharmaceutical composition
ZA95736B (en) Pharmaceutical composition
AU741226C (en) Pharmaceutical composition
AU723097C (en) Pharmaceutical composition
AUPN674495A0 (en) Pharmaceutical composition
AU2002301776A1 (en) Pharmaceutical Composition
AUPN060495A0 (en) Pharmaceutical composition
AUPN175995A0 (en) Pharmaceutical composition
GB9511480D0 (en) Pharmaceutical compositions
GB9505164D0 (en) Pharmaceutical compositions